New drug combo may protect bones after spinal cord injury
NCT ID NCT05101018
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 4 trial tests whether starting with romosozumab for 12 months and then switching to denosumab for another 12 months can better maintain bone density around the knee in people with recent spinal cord injury, compared to using denosumab alone. The study involves 40 adults aged 18-55 who have had a spinal cord injury for less than 6 months. Researchers will measure bone mineral density using X-ray scans to see which approach works best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Romosozumab (Evenity) and Denosumab (Prolia)
What this could lead to
If successful, this could point toward a better treatment sequence to prevent severe bone loss and fractures after spinal cord injury.
What could go wrong
This is a small early-phase trial with only 40 participants, so results may not apply to everyone. Romosozumab carries heart risks, and the study excludes people with heart disease or stroke history.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
James J. Peters VA Medical Center
The Bronx, New York, 10468, United States
-
Kessler Institute for Rehabilitation
West Orange, New Jersey, 07052, United States